<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Parasite Epidemiol Control</span><span class="iso-abbrev" title="iso-abbrev">Parasite Epidemiol Control</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Parasite Epidemiology and Control</span></div><span class="issn-epub" tagx="issn" title="issn-epub">2405-6731</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7817489">7817489</a></span><span class="pii" title="pii">S2405-6731(21)00002-7</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.parepi.2021.e00201">10.1016/j.parepi.2021.e00201</a></span><span class="publisher-id" title="publisher-id">e00201</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Original Research article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
The potential role and apoptotic profile of three medicinal plant extracts on <i>Leishmania tropica</i> by MTT assay, macrophage model and flow cytometry analysis</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ilaghi</span><span class="given-names" tagx="given-names" title="given-names">Mozhde</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharifi</span><span class="given-names" tagx="given-names" title="given-names">Iraj</span></span><span class="email" tagx="email" title="email">iraj.sharifi@yahoo.com</span><a href="#af0005">a</a><a href="#cr0005">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharififar</span><span class="given-names" tagx="given-names" title="given-names">Fariba</span></span><a href="#af0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharifi</span><span class="given-names" tagx="given-names" title="given-names">Fatemeh</span></span><a href="#af0015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oliaee</span><span class="given-names" tagx="given-names" title="given-names">Razieh Tavakoli</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Babaei</span><span class="given-names" tagx="given-names" title="given-names">Zahra</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meimamandi</span><span class="given-names" tagx="given-names" title="given-names">Manzume Shamsi</span></span><a href="#af0020">d</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Keyhani</span><span class="given-names" tagx="given-names" title="given-names">Alireza</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bamorovat</span><span class="given-names" tagx="given-names" title="given-names">Mehdi</span></span><a href="#af0005">a</a></span><span class="citation_author_institution" id="af0005">[a], </span><span class="citation_author_institution" id="af0010">[b], </span><span class="citation_author_institution" id="af0015">[c], </span><span class="citation_author_institution" id="af0020">[d], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Corresponding author at: 22 Bahman Boulevard, Pajouhesh Square, School of Medicine, Department of Medical Parasitology and Mycology, Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. <span class="email" tagx="email" title="email">iraj.sharifi@yahoo.com</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2021-1-1</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2021-2</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-1-1</span></span><span class="volume" tagx="volume" title="volume">12</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">e00201</span><span class="history" title="history"><span class="received" title="received">received: 2020-9-19</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-11-17</span><span class="accepted" title="accepted">accepted: 2021-1-2</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder" />, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2021</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Treatment of leishmaniasis with conventional synthetic drugs is a major global challenge. This study was designed to explore the leishmanicidal activity and apoptotic profile of three leaf extracts on <i>Leishmania tropica</i> stages.</p> </div> <div class="methods" title="sec"> <div class="title" tagx="title" title="title">
Methods</div> <p>The plants of <i>Quercus velutina, Calotropis procera</i> and <i>Nicotiana tabacum</i> were gathered from Anbarabbad county, in the southeastern part of Kerman province and extracted by maceration method using methanol alcohol. Various concentrations of the extracts (1, 10, 100 and 1000Â Î¼g/mL) were used against L. <i>tropica</i> stages to evaluate the inhibitory effect by colorimetric assay, macrophage model and flow cytometry. The MTT assay was conducted to determine the IC<sub>50</sub> and CC<sub>50</sub> values in promastigotes and J774-A1 macrophages, respectively. For intra-macrophage amastigotes, the leishmanicidal activity was evaluated by calculating the mean number of amastigotes in each macrophage and also IC<sub>50</sub> values. The promastigote or amastigote stages with no drug and complete medium without organisms were considered as positive and negative controls, respectively. Meglumine antimoniate (Glucantime) was also used as standard drug. Also, annexin V was used to assess the apoptotic profile. All treatment settings were incubated for a standard time of 72Â h in triplicates. Data were analyzed by <i>t</i>-test and ANOVA.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p>The findings showed that all plant extracts inhibited the proliferation rate of promastigotes and amastigotes (<i>P</i> Ë‚ 0.001); especially, <i>Q. velutina</i> represented the lowest IC<sub>50</sub> in both stages. Besides, <i>Q. velutina</i> showed the least number of amastigotes in each macrophage compared to the other groups (4.5Â Î¼g/mL). The percentage of parasitic apoptosis at 1000Â Î¼g/mL of <i>Q. velutina, C. procera, N. tabacum</i> and GlucantimeÂ® were 37.4, 18.6, 8.5 and 52.4, respectively. Amastigotes (clinical stage) were significantly more susceptible to extracts and also GlucantimeÂ® than promastigotes (<i>P</i>Â <div class="â_UNKNOWN"> </div></p></div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p>This study revealed that all three extracts of <i>Q. velutina, C. procera and N. tabacum</i> exhibited an effective antileishmanial activity and induced apoptosis against the L. <i>tropica</i> promastigotes. Further investigations are essential to isolate and analyze the chemical compositions and their biological properties.</p> </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Medicinal plants</div> <div class="kwd" title="kwd"><i>Leishmania tropica</i></div> <div class="kwd" title="kwd">
Leishmanicidal activity</div> <div class="kwd" title="kwd">
MTT assay</div> <div class="kwd" title="kwd">
Apoptosis role</div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1</span><div class="title" tagx="title" title="title">
Introduction</div> <p id="p0005">Leishmaniasis, a complex protozoan disease which is transmissible between animals and human (<a href="#bb0135"><i>WHO technical report series.</i>, 2010</a>). According to the WHO around 12 million people are currently infected with leishmaniasis in 98 countries, over one billion people are at risk and the annual incidence is 0.7â€"1.2 million (<a href="#bb0005">Alvar et al., 2012</a>). Clinical presentations of the disease are diverse, although two classical forms including visceral leishmaniasis (VL or kala-azar) and cutaneous form (CL) are predominant (<a href="#bb0135"><i>WHO technical report series.</i>, 2010</a>). Cutaneous leishmaniasis, as the most wide-spread and neglected tropical disease consists of approximately 75% of the total case counts. The 6 countries that indicated the highest prevalence of CL including Afghanistan, Algeria, Brazil, Colombia, Iran and Syria (<a href="#bb0005">Alvar et al., 2012</a>).</p> <p id="p0010">At present, synthetic agents such as pentavalent antimonies (GlucantimeÂ® and PentostamÂ®) and various other drugs such as amphotericin B, paromomycin, miltefosine, pentamidine, allopurinol and azole deravatives are used as the first-line and/or second-line alone or in combination for treatment of different types of leishmaniasis. However, the application of these drugs is limited due to low efficacy, high toxicity index, and induction of parasite resistance, long duration of action and high costs (<a href="#bb0050">Croft et al., 2006</a>). Such limitations for use of chemical drugs emphasize an urgent need for discovery of new medicinal alternatives with different mechanism of action, greater potency, shorter treatment cycles, inexpensiveness and availability in endemic countries (<a href="#bb0085">Lamidi et al., 2005</a>).</p> <p id="p0015">There are varieties of biologically active compounds with variable therapeutic potentials in herbal medicines (<a href="#bb0090">Mahmoudvand et al., 2015</a>; <a href="#bb0095">Moein et al., 2017</a>). The use and investigations of medicinal drug remedies on parasites, particularly against <i>Leishmania</i> species have long been well documented by various authors globally (<a href="#bb0035">Barati et al., 2014</a>; <a href="#bb0030">Bajaj et al., 2018</a>). In the present study, among over 15 plants previously screened, three medicinal plant extracts with high index of activity against L. <i>tropica</i> stages including <i>Quercus velutina, Calotropis procera</i> and <i>Nicotiana tobacum</i> were used.</p> <p id="p0020"><i>C. procera</i> is a species of flowering plant in the family <i>Apocynaceae</i> which is used for treatment of intestinal worm, could serve as a source of antidiabetic agent and skin diseases. <i>Q. velutina</i>is a medicinal plant in the family of <i>Fagaceae</i> that is often used as wound disinfectant, treatment of genital infections and acne. <i>N. tobacco</i> is an herbaceous plant in the family of <i>Solanaceae</i> which is cultivated worldwide. According to the WHO nearly one billion people; an estimate of 14% smoke tobacco globally. The main compositions are primarily alkaloids including nicotine, nicotiana, nicotinine and nicoteine. This herb, despite various adverse effects which is banned in many countries, is traditionally used as a relaxant, in chronic asthma, sedative, diuretic, pain reliever, expectorant, wormicidal, antiseptic and sialagogue (<a href="#bb0120">Schulz et al., 2001</a>).</p> <p id="p0025">Apoptosis, as programmed cell death (PCD) is evolved for regulation of cell growth and development in kinetoplastids including <i>Leishmania</i> species similar to other eukaryotes (<a href="#bb0040">Bruchhaus et al., 2007</a>; <a href="#bb0110">Rodrigues et al., 2017</a>). This process is an essential effector mechanism which can play a crucial role to trigger innate and adaptive cell responses against the parasite forms. Further elucidation of the PCD in <i>Leishmania</i> organisms could provide valuable information on biochemical pathways and pathological mechanisms. This could be used to target new drugs for growth limitation of the causative agents and in turn control of the diseases. A typical procedure for detecting phosphatidylserine (PS) is the use of the annexin V. It is a calcium-dependent phospholipid-binding protein which attaches with high affinity to PS of apoptotic promastigotes as demonstrated by flow cytometry (<a href="#bb0060">Doroodgar et al., 2016</a>).</p> <p id="p0030">The aim of this study was to investigate the effect of antileishmanial activities of three medicinal plant extracts on promastigotes and amastigotes (clinical stage) of L. <i>tropica</i> by colorimetric assay and macrophage model, respectively. This study was also designed to analyze the apoptotic profile of the parasite with PI Annexin V by flow cytometry analysis.</p> </div> <div class="materialandmethods" title="sec"><span class="label" tagx="label" title="label">2</span><div class="title" tagx="title" title="title">
Material and methods</div> <div class="plantextracts" title="sec"><span class="label" tagx="label" title="label">2.1</span><div class="title" tagx="title" title="title">
Plant extracts</div> <p id="p0035">In the present study, all three plants were gathered from the southeastern part of Kerman province (Anbarabbad county). The identity of the plants was approved by Professor Fariba Sharififar, Dept. of Pharmacognosy, Faculty of Pharmacy, Kerman University of Medical Sciences. All extracts were prepared by maceration method (<a href="#bb0015">Azwanida, 2015</a>). For each plant, dried leaves were soaked in the methanol, as the solvent, and the system was allowed to stand for three days along with occasional shaking. The materials were thoroughly strained and the maceration processes were performed at room temperate (25Â Â°C). The liquid extracts were allowed to dry in form of powder for use in experimental settings.</p> </div> <div class="controldrug" title="sec"><span class="label" tagx="label" title="label">2.2</span><div class="title" tagx="title" title="title">
Control drug</div> <p id="p0040">GlucantimeÂ® (meglumine antimoniate, MA), as a drug of choice (standard control) for treatment of all clinical forms of leishmaniasis, was prepared from the Center for Diseases Control, Ministry of Health, Iran (manufactured by Sanofi-Aventis, France).</p> </div> <div class="parasiteandcellculture" title="sec"><span class="label" tagx="label" title="label">2.3</span><div class="title" tagx="title" title="title">
Parasite and cell culture</div> <p id="p0045">In this research, the Iranian strain of L. <i>tropica</i> promastigotes (MHOM/IR/75/Mash2) were cultured in 25Â ml flask with RPMI-1640 (Roswell Park Memorial Institute, Biosera) medium, 10% FBS (fetal bovine serum, Biosera) and 2% penicillin and streptomycin at 24Â Â°C incubator. Murine macrophage cells (J774-A1, ATCC no., TIB-67) were purchased from Pasteur Institute of Iran (Tehran, Iran) and cultured in complete medium of RPMI-1640, 10% FBS and 5% penicillin and streptomycin at 37Â Â°C in 5% CO<sub>2</sub> atmosphere<sub>.</sub></p> </div> <div class="cytotoxicityassay" title="sec"><span class="label" tagx="label" title="label">2.4</span><div class="title" tagx="title" title="title">
Cytotoxicity assay</div> <p id="p0050">For evaluation of cytotoxicity on murine macrophages, we determined the CC<sub>50</sub> (cytotoxicity concentration for 50% of cells) of extracts on macrophages. Murine cells were grown at 10<sup>6</sup> cells /mL in 96- well micro plates (Lab-Tek, Nunc, USA) and allowed to adhere for 24Â h at 37Â Â°C and 5% CO<sub>2</sub>. The non-adherent cells were removed by washing with medium, and 190Â Î¼l RPMI-1640 complete medium was added to each well of cells and incubated at the same conditions as mentioned. After that, macrophages were exposed with 10Â Î¼l of different concentrations of extracts (1â€"1000Â Î¼g/mL) and incubated at 37Â Â°C for 72Â h. Finally, the cytotoxicity level was evaluated using the colorimetric assay with MTT test as earlier defined in the promastigote susceptibility assay.</p> </div> <div class="anti-promastigoteinhibitoryeffect" title="sec"><span class="label" tagx="label" title="label">2.5</span><div class="title" tagx="title" title="title">
Anti-promastigote inhibitory effect</div> <p id="p0055">To evaluate the effects of these plant extracts on L. <i>tropica</i> promastigotes, colorimetric cell viability assay was used for estimation of viable cells in multi-well micro plates as described elsewhere (<a href="#bb0125">Shokri et al., 2012</a>). The MTT solution (3-(4, 5-Dimethylthiazol-2-yl)-2, Diphenyltetrazolium Bromide, Sigma Aldrich, USA) consists of tetrazolium which is positively charged and is able to readily penetrates viable cells to reduce the soluble form of MTT into a colored insoluble formozan. Briefly, 100Â Î¼l of logarithmic phase promastigotes (5Â Ã—Â 10<sup>5</sup> cells/ml) were added to a 96-well tissue culture plate. Then, 100Â Î¼l of various concentrations of three methanolic extracts (dissolved in RPMI-1640 medium) and MA reference drug (1, 10, 100 and 1000Â Î¼g/mL) was added to each well and incubated at 25Â Â±Â 1Â Â°C for 48Â h. Afterward, 10Â Î¼l of MTT solution (5Â mg/mL) was added to each well following incubation at 25Â Â°C for 4Â h. For producing a purple color and stop the reaction, cold isopropanol was added to formazan crystals, as a solvent. Finally, the optical density (OD) of each well was read at 495Â nm by an ELISA reader (BioTek-ELX800, USA). Cultured promastigotes with no drug was used as untreated control and medium with no promastigotes and drugs used as blank. Fifty percent inhibitory concentrations (IC<sub>50</sub> values) were calculated for all the tested extracts by using Probit test in SPSS software version 24.</p> </div> <div class="anti-amastigoteinhibitoryeffect" title="sec"><span class="label" tagx="label" title="label">2.6</span><div class="title" tagx="title" title="title">
Anti-amastigote inhibitory effect</div> <p id="p0060">200Â Î¼l of murine macrophages (5Â Ã—Â 10<sup>5</sup> cells/ml) were added to the 6-chamber plates containing sterile slides, following incubation at 37Â Â°C in 5% CO<sub>2</sub> for 2Â h. Then, 200Â Î¼l (25Â Ã—Â 10<sup>5</sup> cells/ml) stationary phase promastigotes were added to macrophages with the ratio of 5:1 for <i>Leishmania</i>/macrophage, and incubated in the same condition for 24Â h. After this incubation period, free parasites were removed by pipetting fresh medium, and the infected macrophages were treated with 70Â Î¼l of methanolic extracts and MA in different concentrations (1, 10, 100 and 1000Â Î¼g/mL) at 37Â Â°C and 5% CO<sub>2</sub> for 72Â h. Ultimately, treated slides were fixed with methanol, dried, Giemsa stained and precisely examined by using a light microscope. Also, amastigote-infected macrophages with no extracts and macrophages with no parasite and extracts were considered as positive and negative groups, respectively. The anti-amastigote inhibitory effect of the extracts was evaluated by calculating the mean number of amastigotes within each cell of 100 macrophages compared to positive control, in triplicates (<a href="#bb0070">Ezatpour et al., 2015</a>). In addition, the IC<sub>50</sub> values were calculated for all the extracts by the probit test in the SPSS software.</p> </div> <div class="flowcytometry" title="sec"><span class="label" tagx="label" title="label">2.7</span><div class="title" tagx="title" title="title">
Flow cytometry</div> <p id="p0065">For determination of apoptosis in promastigotes, we used Apoptosis Detection kit of PI Annexin V- fluorescein isothiocyanate (FITC). Cytoplasmic membrane of the apoptotic cell can be structurally altered by exposing phosphatidylserine on their surface, which can be detected by annexin V (<a href="#bb0025">Bahrami et al., 2016</a>). For this method, 10<sup>6</sup> promastigotes were seeded in 1.5Â mL micro tubes with RPMI-1640 and 10% FBS, then each plant extract or Glucantime Â®at 1000Â Î¼g/mL concentration were added. We incubated them at 24Â Â°C for 72Â h. After this time, promastigotes were centrifuged, washed three times with PBS and resuspended with 1Â mL binding buffer. At last, we added annexin V (5Â Î¼l) to the reaction and incubated at room temperature (25Â Â°C) in dark condition for 20Â min. The results were read by flow cytometry (Becton Dickinson) and analyzed with Cell Quest software. In parallel, settings of untreated and negative control were used.</p> </div> <div class="statisticalanalysis" title="sec"><span class="label" tagx="label" title="label">2.8</span><div class="title" tagx="title" title="title">
Statistical analysis</div> <p id="p0070">The IC<sub>50</sub> and CC<sub>50</sub> values was calculating by using the SPSS version 24 (SPSS Inc., Chicago, USA). Data analysis was carried out by Prism 7.01 software (GraphPad Software, CA, USA). The differences between extract-treated groups and control group or Glucantime were analyzed by ANOVA. Also, <i>t-</i>test was used to analyze the difference between plant extracts. <i>P</i>Â <div class="â_UNKNOWN"> </div></p></div> </div> <div class="results" title="sec"><span class="label" tagx="label" title="label">3</span><div class="title" tagx="title" title="title">
Results</div> <div class="cytotoxicity" title="sec"><span class="label" tagx="label" title="label">3.1</span><div class="title" tagx="title" title="title">
Cytotoxicity</div> <p id="p0075"><i>In vitro</i> susceptibility assay displayed no significant cytotoxicity effect in our extracts, as the selectivity index (SI) was 16.2, 7.67, 7.12 and 1.01 for <i>Q. velutina</i>, <i>C. procera</i>, <i>N. tabacum</i> and GlucantimeÂ®, respectively (<a href="#t0005">Table 1</a>). SI â‰¥10 was considered nontoxic. As shown in <a href="#f0005">Fig. 1</a>, <i>Q. velutina</i> represented the highest viability of J774 cells in various concentrations compared to the other extracts and GlucantimeÂ®. Besides, GlucantimeÂ® caused significant lower viability of J774 cells in comparison to three plant extracts, especially in the last four concentrations (<i>P</i>Â <div class="â_UNKNOWN" position="float" id="t0005"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>IC<sub>50</sub> values of <i>Quercus velutina</i>, <i>Calotropis procera</i> and <i>Nicotiana tabacum</i> against the growth rate of promastigotes and amastigotes of <i>Leishmania tropica</i> compared with GlucantimeÂ® as positive control and the CC<sub>50</sub> values of drugs on macrophage using the SI index. Data are expressed as the meanÂ Â±Â SD.</p>  <div tag="alt-text">
Table 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th rowspan="2"><br /><br />Extracts</th> <th colspan="2">Amastigote <hr /> </th> <th colspan="2">Promastigote <hr /> </th> <th>Macrophage <hr /> </th> <th><a href="#tf0015">c</a>SI <hr /> </th> </tr> <tr> <th><a href="#tf0005">a</a>IC<sub>50</sub> Â± SD (Î¼g/mL)</th> <th><i>P</i>-value</th> <th><a href="#tf0005">a</a>IC<sub>50</sub> Â± SD (Î¼g/mL)</th> <th><i>P</i>-value</th> <th><a href="#tf0010">b</a>CC<sub>50</sub> (Î¼g/mL)</th> <th>(Selectivity Index)</th> </tr> </thead> <tbody> <tr> <td>GlucantimeÂ®</td> <td>236.3Â Â±Â 0.1</td> <td>NR</td> <td>588.3Â Â±Â 0.1</td> <td>NR</td> <td>240.6Â Â±Â 0. 3</td> <td>1.01</td> </tr> <tr> <td><i>Quercus velutina</i></td> <td>51.2Â Â±Â 0.1</td> <td><i>P</i>Â <div class="â_UNKNOWN"> </div></td><td>132.6Â Â±Â 0.2</td> <td><i>P</i>Â <div class="â_UNKNOWN"> </div></td><td>830.3Â Â±Â 0. 3</td> <td>16.2</td> </tr> <tr> <td><i>Calotropis procera</i></td> <td>95.2Â Â±Â 0.1</td> <td><i>P</i>Â <div class="â_UNKNOWN"> </div></td><td>248.1Â Â±Â 0.2</td> <td><i>P</i>Â <div class="â_UNKNOWN"> </div></td><td>730.6Â Â±Â 0. 7</td> <td>7.67</td> </tr> <tr> <td><i>Nicotiana tabacum</i></td> <td>118.3Â Â±Â 0.1</td> <td><i>P</i>Â <div class="â_UNKNOWN"> </div></td><td>571.2Â Â±Â 0.1</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> <td>843.4Â Â±Â 0. 3</td> <td>7.12</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>NR: Not related.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p id="np0005">IC<sub>50</sub>, Concentration of drug that inhibited 50% of growth in promastigotes and amastigotes.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">b</span><p id="np0010">CC<sub>50</sub>, Concentration of drug that inhibited 50% of growth in macrophages.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">c</span><p id="np0015">SI, Selectivity index (CC<sub>50</sub>/IC<sub>50</sub>).</p> </div> </div>  <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Cell viability of different concentrations of <i>Quercus velutina</i>, <i>Calotropis procera</i> and <i>Nicotiana tabacum</i> against murine macrophages (J774 cells) in comparison with GlucantimeÂ® and untreated control (***<i>P</i>Â <div class="â_UNKNOWN">   </div></p></div> <p /> </div> <div class="anti-promastigoteroleassessment" title="sec"><span class="label" tagx="label" title="label">3.2</span><div class="title" tagx="title" title="title">
Anti-promastigote role assessment</div> <p id="p0080">The findings demonstrated that methanolic extracts displayed effective antileishmanial activities with a dose-response effect against the promastigote stage of L. <i>tropica</i> at all concentrations used; particularly <i>Q. velutina</i> showed the lowest viability of promastogotes at concentrations of 100 and 1000Â Î¼g/mL (<i>P</i>Â <div class="â_UNKNOWN" href="#f0010">
Fig. 2). The OD values at different concentrations (10, 100 and 1000Â Î¼g/mL) of the three medicinal extracts were significantly lower than the corresponding untreated control groups (<i>P</i> Ë‚ 0.001). All extracts exhibited similar pattern of action in reducing tetrazolium; although, GlucantimeÂ® exerted more profound activity compared with the control group. The IC<sub>50</sub> value for <i>Q. velutina</i> was 132.6Â Î¼g/mL, followed by <i>C. procera</i> 248.1Â Î¼g/mL and <i>N. tabacum</i> 571.2Â Î¼g/mL against promastigotes, whereas this value was 588.3Â Î¼g/mL for GlucantimeÂ® (<a href="#t0005">Table 1</a>). As shown, the IC<sub>50</sub> value of <i>Q. velutina</i> and <i>C. procera</i> represented significant lower IC<sub>50</sub> compared to GlucantimeÂ® as control drug (<i>P</i>Â <div class="â_UNKNOWN">
N. tabacum did not. The minimum inhibitory concentration (MIC) for both extracts and GlucantimeÂ® was 10Â Î¼g/mL (the least dose inhibited the growth rates of L. <i>tropica</i> stages, in the present investigation). </div></div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 2</span></a></div>   <p>The viability percent of <i>Quercus velutina</i>, <i>Calotropis procera</i>, and <i>Nicotiana tabacum</i> against <i>Leishmania tropica</i> promastigotes compared to Glucantime (***<i>P</i>Â <div class="â_UNKNOWN">   </div></p></div> <p /> </div> <div class="anti-amastigoteroleassessment" title="sec"><span class="label" tagx="label" title="label">3.3</span><div class="title" tagx="title" title="title">
Anti-amastigote role assessment</div> <p id="p0085">The results showed that different concentrations of three methanolic extracts and GlucantimeÂ® decreased the growth rate of amastigotes (clinical stage). Our plant extracts demonstrated significant reduction in the mean number of amastigotes in cells compared to untreated control at all concentrations, except at 1Â Î¼g/mL (<i>P</i>Â â‰¤Â 0.01). Besides, <i>Q. velutina</i> represented more reducing effect on the amastigotes in comparison to the other extracts and GlucantimÂ®e, especially at 1000Â Î¼g/mL concentrations (<i>P</i>Â â‰¤Â 0.01) (<a href="#f0015">Fig. 3</a>, <a href="#t0010">Table 2</a>). Also, the IC<sub>50</sub> value for <i>Q. velutina</i> was 51.2Â Î¼g/mL, followed by <i>C. procera</i> 95.2Â Î¼g/mL and <i>N. tabacum</i> 118.3Â Î¼g/mL against amastigotes, whereas this value was 236.3Â Î¼g/mL for GlucantimeÂ® as control drug (<a href="#t0005">Table 1</a>). All extracts showed significant reduction in the IC<sub>50</sub> value of amastigotes compared to GlucantimeÂ® (<i>P</i>Â â‰¤Â 0.001), as <i>Q. velutina</i> showed the lowest one. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 3</span></a></div>   <p>The viability percent of <i>Quercus velutina</i>, <i>Calotropis procera</i> and <i>Nicotiana tabacum</i> against <i>Leishmania tropica</i> amastigotes compared to GlucantimeÂ® (***<i>P</i>Â <div class="â_UNKNOWN">   </div></p></div> <div class="table-wrap_UNKNOWN" position="float" id="t0010"><span class="label" tagx="label" title="label">Table 2</span> <p>The effect of various concentrations of <i>Quercus velutina</i>, <i>Calotropis procera</i>, <i>Nicotiana tabacum</i> extracts and GlucantimeÂ® on the mean number of intramacrophage amastigotes of <i>Leishmania tropica</i> in each macrophage.</p>  <div tag="alt-text">
Table 2</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Concentration<br /><br />(Î¼g/mL)</th> <th colspan="2"><i>Q. velutina</i><br /><br />MeanÂ Â±Â SD <i>P</i> value</th> <th colspan="2"><i>C. procera</i><br /><br />MeanÂ Â±Â SD <i>P</i> value</th> <th colspan="2"><i>N. tabacum</i><br /><br />MeanÂ Â±Â SD <i>P</i> value</th> <th colspan="2">GlucantimeÂ®<br /><br />MeanÂ Â±Â SD <i>P</i> value</th> </tr> </thead> <tbody> <tr> <td>Control</td> <td>96.6Â Â±Â 0.4</td> <td>NR</td> <td>96.4Â Â±Â 0.4</td> <td>NR</td> <td>96.4Â Â±Â 0.4</td> <td>NR</td> <td>96.4Â Â±Â 0.4</td> <td>NR</td> </tr> <tr> <td>1</td> <td>89.6Â Â±Â 0.6</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> <td>88.8Â Â±Â 0.4</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> <td>98.7Â Â±Â 1.1</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> <td>88.0Â Â±Â 0.6</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> </tr> <tr> <td>10</td> <td>71.6Â Â±Â 0.6</td> <td><i>P</i>Â â‰¤Â 0.01</td> <td>79.8Â Â±Â 0.4</td> <td><i>P</i>Â â‰¤Â 0.01</td> <td>80.7Â Â±Â 1.1</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> <td>86.0Â Â±Â 0.6</td> <td><i>P</i>Â &amp;gt;Â 0.05</td> </tr> <tr> <td>100</td> <td>56.3Â Â±Â 0.3</td> <td><i>P</i>Â â‰¤Â 0.01</td> <td>58.4Â Â±Â 0.4</td> <td><i>P</i>Â â‰¤Â 0.01</td> <td>59.3Â Â±Â 0.4</td> <td><i>P</i>Â â‰¤Â 0.01</td> <td>59.7Â Â±Â 0.4</td> <td><i>P</i>Â â‰¤Â 0.01</td> </tr> <tr> <td>1000</td> <td>4.5Â Â±Â 0.3</td> <td><i>P</i>Â â‰¤Â 0.001</td> <td>15.8Â Â±Â 0.1</td> <td><i>P</i>Â â‰¤Â 0.001</td> <td>16.0Â Â±Â 0.5</td> <td><i>P</i>Â â‰¤Â 0.001</td> <td>32.5Â Â±Â 0.1</td> <td><i>P</i>Â â‰¤Â 0.001</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>NR: Not related.</p> </div> </div> </div> <p /> </div> <div class="apoptosisanalysis" title="sec"><span class="label" tagx="label" title="label">3.4</span><div class="title" tagx="title" title="title">
Apoptosis analysis</div> <p id="p0090">The results showed that the medicinal extracts displayed different PCD effect on promastigotes of L. <i>tropica</i>. The percent of apoptosis at 1000Â Î¼g/mL for <i>Q. velutiona</i>, <i>C.procera</i>, <i>N. tabacum</i> and GlucantimeÂ® were 37.4%, 18.6%, 8.5% and 52.4%, respectively. GlucantimeÂ® induced more apoptotic effect than the plant extracts. Also, <i>Q. velutiona</i> represented higher apoptotic effect compared to other extracts (<a href="#f0020">Fig. 4</a>). The apoptotic value of residual methanol used in the plant extracts was negligible (2.3%). Interestingly, the PCD was conversely incremented by increasing the concentration of GlucantimeÂ® (<a href="#t0015">Table 3</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 4</span></a></div>   <p>Apoptotic profiles of <i>Leishmania tropica</i> promastigotes with annexin V at 1000Â Î¼g/ml of <i>Q. velutina</i> (A), <i>C. procera</i> (B), <i>N. tabacum</i> (C), GlucantimeÂ® (D), methanol (E) and negative control (F). M<sub>1</sub> is a region that the organisms show no apoptosis and M<sub>2</sub> showing apoptotic organisms.</p>   </div> <div class="table-wrap_UNKNOWN" position="float" id="t0015"><span class="label" tagx="label" title="label">Table 3</span> <p>Apoptosis percentage of <i>Q. velutiona</i>, <i>C. procera</i>, <i>N. tabacum</i> and GlucantimeÂ® by flow cytometry analysis.</p>  <div tag="alt-text">
Table 3</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Treatment</th> <th>Concentration (Î¼g/ml)</th> <th>Apoptosis (%)</th> </tr> </thead> <tbody> <tr> <td><i>Quercus velutina</i></td> <td>1000</td> <td>37.4</td> </tr> <tr> <td><i>Calotropis procera</i></td> <td>1000</td> <td>18.6</td> </tr> <tr> <td><i>Nicotina tobacco</i></td> <td>1000</td> <td>8.5</td> </tr> <tr> <td>GlucantimeÂ®</td> <td>1000</td> <td>52.4</td> </tr> <tr> <td>GlucantimeÂ®</td> <td>100</td> <td>12.5</td> </tr> <tr> <td>Glucantime</td> <td>10</td> <td>9.3</td> </tr> <tr> <td>Methanol</td> <td>NR</td> <td>2.3</td> </tr> <tr> <td>control</td> <td>NR</td> <td>0.4</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>NR: Not related.</p> </div> </div> </div> <p /> </div> </div> <div class="discussion" title="sec"><span class="label" tagx="label" title="label">4</span><div class="title" tagx="title" title="title">
Discussion</div> <p id="p0095">To our knowledge, this is the first investigation on the leishmanicidal effects of these three plant extracts. In the present study the methanolic extracts demonstrated a good index of antileishmanial activity against both stages of L. <i>tropica</i> as they proved to be effective in inhibiting the replication rate of promastigotes and intra-macrophage amastigotes. The MIC was 1000Â Î¼g/ml for the extracts and also GlucantimeÂ® which expressed a similar inhibitory action when the overall potential strength is being considered. Additionally, this leishmanicidal activity could be confirmed by the low OD or IC<sub>50</sub> values.</p> <p id="p0100">Recent global data indicate that leishmaniasis has become a major medical and veterinary health concern as documented in many endemic countries (<a href="#bb0135"><i>WHO technical report series.</i>, 2010</a>; <a href="#bb0005">Alvar et al., 2012</a>). Control of this disease is complicated because of the presence of numerous species of vectors and reservoirs (<a href="#bb0010">Ashford, 2000</a>). Treatment of various clinical and epidemiological forms with pentavalent antimonial agents, as the first- standard drugs, over the past 70Â years, is unsatisfactory. The choice of so many second-line compounds alone or in combination is also very limited. At present, there is no vaccine available (<a href="#bb0100">Noazin et al., 2008</a>). Therefore, current efforts have been focused on discovering and use of new therapeutic natural agents as they provide rich and potential source of bioactive antileishmanial products.</p> <p id="p0105">Natural products, such as medicinal extracts, as crude compounds or pure standardized extracts could provide a valuable source for new medicines due to availability of bioactive compounds, accessibility, safety and low costs (<a href="#bb0045">Cos et al., 2006</a>). According to the WHO, approximately 80% of the world's population somehow relies on traditional remedies for their primary healthcare needs. The use of herbal medicines represents a long history of human interactions with the surrounding environment across the globe. Plants used in traditional medicine comprise a wide range of potential compositions that can be essential to treat various disease syndromes caused by infectious agents (<a href="#bb0105">Rocha et al., 2005</a>).</p> <p id="p0110">The apoptotic program is evolved to regulate cell growth and development in kinetoplastids including <i>Leishmania</i> species similar to other eukaryotes (<a href="#bb0060">Doroodgar et al., 2016</a>; <a href="#bb0025">Bahrami et al., 2016</a>). Programmed cell death is an essential effector mechanism which can play a central role to trigger innate and adaptive cell responses against the parasites (<a href="#bb0055">de Freitas Balanco et al., 2001</a>). Further elucidation of the PCD in <i>Leishmania</i> could provide valuable information on pathogenesis and biological processing which might be used to target new effective drugs for growth inhibition. Moreover, it was previously suggested that L. <i>tropica</i> promastigotes uniformly express phosphatidylserine in their stationary phase (<a href="#bb0130">Tripathi and Gupta, 2003</a>). As revealed the leishmanicidal effects of the above plant extracts was in part mediated through PCD as documented by externalization of PS.</p> <p id="p0115">Over the past decades extensive efforts have been made to develop new drug alternatives in endemic countries. In general, a wide range of antileishmanial plant extracts have been evaluated as evidenced from Iran (<a href="#bb0020">Bahmani et al., 2015</a>), French Guiana (<a href="#bb0105">Rocha et al., 2005</a>), India (<a href="#bb0115">Samuelsson and Bohlin, 2017</a>), Israel (<a href="#bb0065">El-On, 2009</a>) and Greece (<a href="#bb0075">Fokialakis et al., 2007</a>). There seem new approaches toward the natural products, in absence of effective agents would be a logical strategy (<a href="#bb0080">Harvey et al., 2015</a>). Unfortunately; although, despite the use of natural products in endemic countries only a limited effort has been made to isolate and analyze their chemical antileishmanial compositions to conduct clinical trials.</p> </div> <div class="conclusion" title="sec"><span class="label" tagx="label" title="label">5</span><div class="title" tagx="title" title="title">
Conclusion</div> <p id="p0120">The findings of this study demonstrate effective antileishmanial activities for the three crude extracts that can be used as a natural source for production of new leishmanicidal agents against CL. However, further experimental and clinical studies are required to isolate and analyze their chemical compositions for final evaluation of biological activities of <i>Q. velutina, C. procera, and N. tabacum</i> in animal models as well as in human volunteers as new therapeutic agents.</p> </div> <div class="financialsupport" title="sec"> <div class="title" tagx="title" title="title">
Financial Support</div> <p id="p0125">This investigation was supported by the Leishmaniasis Research Center and Vice Chancellor for Research, </p><div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">10.13039/501100004621</span><span class="institution" title="institution">Kerman University of Medical Sciences</span></div> </div> (protocol no. 94/228). The funder had no role in the study design, data collection, data analysis and manuscript preparation.<p /> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Declaration of Competing Interest</div> <p id="p0130">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p> <p id="p0135">The authors declare the following financial interests/personal relationships which may be considered as potential competing interests</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bb0005" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alvar</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">VÃ©lez</span><span class="given-names" tagx="given-names" title="given-names">I.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bern</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Herrero</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Desjeux</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cano</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Leishmaniasis worldwide and global estimates of its incidence</span><span class="source" tagx="source" title="source">PLoS One</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2012</span>e35671</span></li> <li tag="ref"><a name="bb0010" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ashford</span><span class="given-names" tagx="given-names" title="given-names">R.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The leishmaniases as emerging and reemerging zoonoses</span><span class="source" tagx="source" title="source">Int. J. Parasitol.</span><span class="volume" tagx="volume" title="volume">30</span><span class="year" tagx="year" title="year">2000</span><span class="fpage" tagx="fpage" title="fpage">1269</span><span class="lpage" tagx="lpage" title="lpage">1281</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11113254">11113254</a></span></span></li> <li tag="ref"><a name="bb0015" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azwanida</span><span class="given-names" tagx="given-names" title="given-names">N.N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A review on the extraction methods use in medicinal plants, principle, strength and limitation</span><span class="source" tagx="source" title="source">Med Aromat Plants.</span><span class="volume" tagx="volume" title="volume">4</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">412</span><span class="lpage" tagx="lpage" title="lpage">2167</span></span></li> <li tag="ref"><a name="bb0020" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bahmani</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saki</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ezatpour</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shahsavari</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Eftekhari</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jelodari</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Leishmaniosis phytotherapy: review of plants used in Iranian traditional medicine on leishmaniasis</span><span class="source" tagx="source" title="source">Asian Pac. J. Trop. Biomed.</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">695</span><span class="lpage" tagx="lpage" title="lpage">701</span></span></li> <li tag="ref"><a name="bb0025" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bahrami</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khademvatan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Razi Jalali</span><span class="given-names" tagx="given-names" title="given-names">M.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pourbaram</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Amiodarone triggers induction of apoptosis in cutaneous leishmaniasis agents</span><span class="source" tagx="source" title="source">Pathogens and global health.</span><span class="volume" tagx="volume" title="volume">110</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">200</span><span class="lpage" tagx="lpage" title="lpage">204</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27553974">27553974</a></span></span></li> <li tag="ref"><a name="bb0030" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bajaj</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wakode</span><span class="given-names" tagx="given-names" title="given-names">S.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khan</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manchanda</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kumar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Simultaneous HPTLC analysis and in vitro antileishmanic activity of various secondary metabolites in extract of the traditional medicinal herb Artabotrys hexapetalus (lf)</span><span class="source" tagx="source" title="source">Ayu.</span><span class="volume" tagx="volume" title="volume">39</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">92</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30783364">30783364</a></span></span></li> <li tag="ref"><a name="bb0035" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barati</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharifi</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharififar</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hakimi Parizi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shokri</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-leishmanial activity of gossypium hirsutum L., Ferula Assa-foetida L. and Artemisia aucheri Boiss. Extracts by colorimetric assay</span><span class="source" tagx="source" title="source">Anti-Infective Agents.</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">159</span><span class="lpage" tagx="lpage" title="lpage">164</span></span></li> <li tag="ref"><a name="bb0040" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruchhaus</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roeder</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rennenberg</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Heussler</span><span class="given-names" tagx="given-names" title="given-names">V.T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Protozoan parasites: programmed cell death as a mechanism of parasitism</span><span class="source" tagx="source" title="source">Trends Parasitol.</span><span class="volume" tagx="volume" title="volume">23</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">376</span><span class="lpage" tagx="lpage" title="lpage">383</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17588817">17588817</a></span></span></li> <li tag="ref"><a name="bb0045" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cos</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vlietinck</span><span class="given-names" tagx="given-names" title="given-names">A.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vanden</span><span class="given-names" tagx="given-names" title="given-names">Berghe D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maes</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-infective potential of natural products: how to develop a stronger in vitro â€˜proof-of-concept</span><span class="source" tagx="source" title="source">J. Ethnopharmacol.</span><span class="volume" tagx="volume" title="volume">106</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">290</span><span class="lpage" tagx="lpage" title="lpage">302</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16698208">16698208</a></span></span></li> <li tag="ref"><a name="bb0050" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Croft</span><span class="given-names" tagx="given-names" title="given-names">S.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seifert</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yardley</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Current scenario of drug development for leishmaniasis</span><span class="source" tagx="source" title="source">Indian J. Med. Res.</span><span class="volume" tagx="volume" title="volume">123</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">399</span><span class="lpage" tagx="lpage" title="lpage">410</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16778319">16778319</a></span></span></li> <li tag="ref"><a name="bb0055" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Freitas Balanco</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moreira</span><span class="given-names" tagx="given-names" title="given-names">M.E.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bonomo</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bozza</span><span class="given-names" tagx="given-names" title="given-names">P.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Amarante-Mendes</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pirmez</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity</span><span class="source" tagx="source" title="source">Curr. Biol.</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2001</span><span class="fpage" tagx="fpage" title="fpage">1870</span><span class="lpage" tagx="lpage" title="lpage">1873</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11728310">11728310</a></span></span></li> <li tag="ref"><a name="bb0060" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doroodgar</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delavari</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doroodgar</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abbasi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Taherian</span><span class="given-names" tagx="given-names" title="given-names">A.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doroodgar</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Tamoxifen induces apoptosis of Leishmania major promastigotes in vitro</span><span class="source" tagx="source" title="source">The Korean journal of parasitology.</span><span class="volume" tagx="volume" title="volume">54</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">9</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26951973">26951973</a></span></span></li> <li tag="ref"><a name="bb0065" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-On</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Current status and perspectives of the immunotherapy of leishmaniasis</span><span class="source" tagx="source" title="source">The Israel Medical Association Journal: IMAJ.</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">623</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20077951">20077951</a></span></span></li> <li tag="ref"><a name="bb0070" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ezatpour</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saedi Dezaki</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mahmoudvand</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azadpour</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ezzatkhah</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro and in vivo antileishmanial effects of Pistacia khinjuk against Leishmania tropica and Leishmania major</span><span class="source" tagx="source" title="source">Evid. Based Complement. Alternat. Med.</span><span class="volume" tagx="volume" title="volume">2015</span><span class="year" tagx="year" title="year">2015</span></span></li> <li tag="ref"><a name="bb0075" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fokialakis</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalpoutzakis</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tekwani</span><span class="given-names" tagx="given-names" title="given-names">B.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khan</span><span class="given-names" tagx="given-names" title="given-names">S.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kobaisy</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Skaltsounis</span><span class="given-names" tagx="given-names" title="given-names">A.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluation of the antimalarial and antileishmanial activity of plants from the Greek island of Crete</span><span class="source" tagx="source" title="source">J. Nat. Med.</span><span class="volume" tagx="volume" title="volume">61</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">38</span><span class="lpage" tagx="lpage" title="lpage">45</span></span></li> <li tag="ref"><a name="bb0080" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Harvey</span><span class="given-names" tagx="given-names" title="given-names">A.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Edrada-Ebel</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Quinn</span><span class="given-names" tagx="given-names" title="given-names">R.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The re-emergence of natural products for drug discovery in the genomics era</span><span class="source" tagx="source" title="source">Nat. Rev. Drug Discov.</span><span class="volume" tagx="volume" title="volume">14</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">111</span><span class="lpage" tagx="lpage" title="lpage">129</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25614221">25614221</a></span></span></li> <li tag="ref"><a name="bb0085" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lamidi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DiGiorgio</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delmas</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Favel</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mve-Mba</span><span class="given-names" tagx="given-names" title="given-names">C.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rondi</span><span class="given-names" tagx="given-names" title="given-names">M.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants</span><span class="source" tagx="source" title="source">J. Ethnopharmacol.</span><span class="volume" tagx="volume" title="volume">102</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">185</span><span class="lpage" tagx="lpage" title="lpage">190</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16046090">16046090</a></span></span></li> <li tag="ref"><a name="bb0090" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mahmoudvand</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ezzatkhah</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharififar</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharifi</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dezaki</span><span class="given-names" tagx="given-names" title="given-names">E.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antileishmanial and cytotoxic effects of essential oil and methanolic extract of Myrtus communis L</span><span class="source" tagx="source" title="source">The Korean journal of parasitology.</span><span class="volume" tagx="volume" title="volume">53</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">21</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25748705">25748705</a></span></span></li> <li tag="ref"><a name="bb0095" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moein</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hatam</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Taghavi-Moghadam</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zarshenas</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antileishmanial activities of Greek Juniper (<i>Juniperus excelsa</i> M Bieb.) against leishmania major promastigotes</span><span class="source" tagx="source" title="source">Journal of evidence-based complementary &amp;amp; alternative medicine</span><span class="volume" tagx="volume" title="volume">22</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">31</span><span class="lpage" tagx="lpage" title="lpage">36</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26747836">26747836</a></span></span></li> <li tag="ref"><a name="bb0100" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noazin</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Modabber</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khamesipour</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">P.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moulton</span><span class="given-names" tagx="given-names" title="given-names">L.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nasseri</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">First generation leishmaniasis vaccines: a review of field efficacy trials</span><span class="source" tagx="source" title="source">Vaccine.</span><span class="volume" tagx="volume" title="volume">26</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">6759</span><span class="lpage" tagx="lpage" title="lpage">6767</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18950671">18950671</a></span></span></li> <li tag="ref"><a name="bb0105" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rocha</span><span class="given-names" tagx="given-names" title="given-names">L.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Almeida</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Macedo</span><span class="given-names" tagx="given-names" title="given-names">R.O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barbosa-Filho</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A review of natural products with antileishmanial activity</span><span class="source" tagx="source" title="source">Phytomedicine.</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">514</span><span class="lpage" tagx="lpage" title="lpage">535</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16008131">16008131</a></span></span></li> <li tag="ref"><a name="bb0110" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Rodrigues JCF, Seabra SH, de Souza W. Apoptosis-like death in parasitic protozoa. Journal of Morphological Sciences. 2017;23: 0.</span></li> <li tag="ref"><a name="bb0115" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Samuelsson</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bohlin</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Drugs of Natural Origin: A Treatise of Pharmacognosy</span><span class="year" tagx="year" title="year">2017</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">CRC Press Inc.</span></span></li> <li tag="ref"><a name="bb0120" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schulz</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">HÃ¤nsel</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tyler</span><span class="given-names" tagx="given-names" title="given-names">V.E.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Rational Phytotherapy: A physicianâ€™s Guide to Herbal Medicine</span><span class="year" tagx="year" title="year">2001</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Psychology Press</span></span></li> <li tag="ref"><a name="bb0125" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shokri</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharifi</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khamesipour</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nakhaee</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Harandi</span><span class="given-names" tagx="given-names" title="given-names">M.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nosratabadi</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate</span><span class="source" tagx="source" title="source">Parasitol. Res.</span><span class="volume" tagx="volume" title="volume">110</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">1113</span><span class="lpage" tagx="lpage" title="lpage">1117</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21847598">21847598</a></span></span></li> <li tag="ref"><a name="bb0130" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tripathi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">C.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in Leishmania promastigotes</span><span class="source" tagx="source" title="source">Mol. Biochem. Parasitol.</span><span class="volume" tagx="volume" title="volume">128</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">9</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12706791">12706791</a></span></span></li> <li tag="ref"><a name="bb0135" /><span class="element-citation'"><span class="issue-title" tagx="issue-title" title="issue-title">World Health Organization (WHO). Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland, 22-26</span><span class="source" tagx="source" title="source">WHO technical report series.</span><span class="year" tagx="year" title="year">March 2010</span><span class="fpage" tagx="fpage" title="fpage">2010</span></span></li> </ul> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p id="p0140">The authors would like to appreciate all of the staff of Leishmaniasis Research Center for their immense assistance in performing this research.</p> </div> </div>  </body></html>